Signaturefd, LLC Cytosorbents Corp Transaction History

Signaturefd, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 28, 2021	SELL	$7.0 - $9.71 $392 - $543	-56 Closed	0 $0
Q2 2021 Jul 26, 2021	BUY	$7.55 - $9.42 $422 - $527	56 New	56 $0
Q1 2021 Apr 30, 2021	SELL	$8.23 - $11.48 $1,876 - $2,617	-228 Closed	0 $0
Q3 2020 Nov 03, 2020	SELL	$7.37 - $11.54 $1,680 - $2,631	-228 Reduced 50.0%	228 $2,000
Q2 2020 Jul 30, 2020	BUY	$6.28 - $10.59 $2,863 - $4,829	456 New	456 $5,000

16.9M

10.1K

500

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $51.9M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.